Propanc's PRP Increases Chemotherapy Sensitivity in Pancreatic Cancer Cells in Preclinical Study
Propanc Biopharma reported preclinical findings showing PRP pretreatment increased chemotherapy responsiveness in chemotherapy-resistant pancreatic cancer cells. Sequential PRP treatment followed by chemotherapy produced the study’s strongest functional response. PRP alone reduced proliferation by 54% in resistant cell